Susquehanna International Group, LLP Sutro Biopharma, Inc. Call Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $174,933 - $459,134	51,300 Added 309.04%	67,900 $354,000
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $734,498 - $996,948	-36,200 Reduced 68.56%	16,600 $378,000
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $536,448 - $1.27 Million	52,800 New	52,800 $1.15 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $96.5M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.